- Home
- Products
YERVOY
YERVOY
- Medicine Name: YERVOY
- Generic Name: Ipilimumab
- Dosage Form & Strength: 50 mg (5 mg/mL) and 200 mg (5 mg/mL) single-use vials
- Manufactured By:Bristol-Myers Squibb Company
- FDA Approval: Yes (Approved in March 2011)
Ipilimumab is a monoclonal antibody used to treat unresectable or metastatic melanoma, a severe form of skin cancer.
Approved indications include:
- Late-stage melanoma that has spread or cannot be surgically removed
- Adjuvant treatment in stage III melanoma patients after tumor and lymph node removal
- Being explored for other cancers in clinical trials including NSCLC, prostate cancer, bladder cancer, and small-cell lung cancer
How It Works:
Ipilimumab enhances the immune system’s ability to fight cancer by blocking CTLA-4, a protein that downregulates immune activity. This enables T-cells to better recognize and attack melanoma cells.
Dosage Form:
Administered via intravenous infusion over 90 minutes. Supplied in 50 mg and 200 mg single-use vials.
Is YERVOY available in India?
YERVOY is not commercially available or approved by Indian drug authorities but can be imported on a Named Patient basis.
Required Documents for Import:
- Valid prescription from an oncologist
- Patient’s diagnostic reports
- Government-issued photo ID proof
- Import permit (if applicable)
Verification Prior to Purchase:
Patients should confirm:
- Import and packaging process
- Shipping and courier details
- Supplier verification (license, warehouse registration)
- Customs clearance documents such as bill of entry
- Avoid cash-based purchases
Generic Availability:
There is no generic or biosimilar version of Ipilimumab available anywhere in the world.
Delivery Locations:
Product can be made available across India including Mumbai, Delhi, Bangalore, Chennai, Hyderabad, Ahmedabad, Pune, Jaipur, Chandigarh, and other cities after compliance with documentation.
Global Rare Meds sources Ipilimumab (YERVOY) from trusted pharmaceutical suppliers in the USA, Europe, and other regulatory-compliant countries.
- Handled by licensed professionals at our Ambernath (Thane District) fulfillment center
- Product is cold chain managed and shipped under regulated conditions
- Timely delivery across India and globally, based on legal permissions
We ensure complete traceability, product authenticity, and import compliance for every order.
What is the generic name of YERVOY?
Ipilimumab
Who manufactures YERVOY?
Bristol-Myers Squibb Company
When was Ipilimumab approved by the FDA?
Ipilimumab received FDA approval in March 2011.
What are the available vial strengths?
Ipilimumab is supplied in 50 mg and 200 mg single-use vials.
How is Ipilimumab stored?
Store between 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light.
What cancers is Ipilimumab used for?
Primarily for metastatic melanoma, and under clinical trials for several others.
Is Ipilimumab available in generic form?
No, there are no approved generics or biosimilars available globally.
How can I obtain Ipilimumab in India?
You can contact Global Rare Meds for availability and documentation requirements:
Phone: +91-99675 15602
WhatsApp: +91-99675 15602
Email: info@globalraremeds.com
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
